Company intelligence / Profile preview
pHLIP, Inc.
Kingston, Rhode Island, United Statesphlipinc.com ↗
- Ownership
- Private
- Development stage
- Other
01
Overview
Currently in Phase II clinical trial for its proprietary pHLIP ICG surgical imaging agent for breast cancer and evaluating therapeutic pHLIP Drug Conjugates (PDCs) for clinical translation. A sublicensee, Cybrexa, has begun Phase 2 trials in ovarian cancer with CBX-12 (pHLIP exatecan).
- Therapeutic areas
- OncologyRare DiseasesImmunology
- Modalities
- Peptide-based drug conjugatesRNA-based therapeuticsgene therapies
- Industry
- Biotech
02
Drug pipeline
2 assets1 more asset in the full pipeline.
03
Partnerships
CordenPharma InternationalCybrexa Therapeutics (sublicensee)
Beyond the preview
Go deeper on pHLIP, Inc..
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Clinical trials
Follow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Licensing & deals
Explore licensing agreements, acquisitions, and the assets behind each deal.
- Partners
- Deal terms
- Milestones
Funding history
Trace financing activity and the investors behind a company’s development.
- Funding rounds
- Investors
- Capital raised
Competitive landscape
Compare peer pipelines by target, modality, and therapeutic area.
- Peer companies
- Targets
- Pipeline overlap
Technologies & patents
Explore technology platforms and the patent landscape around relevant assets.
- Platforms
- Patents
- Assignees
Research & analysis
Connect company news and source material to the questions you’re investigating.
- Company news
- Sources
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on pHLIP, Inc..